I've launched products at four different companies. Two succeeded. Two didn't. The difference wasn't the product. It was the GTM plan. The successful launches had a narrow ICP, a pricing model validated by real buyers, and a sales motion tested before scaling. The failures had broad targets, aspirational pricing, and a sales team hired before anyone understood who was actually buying.

Go-to-market strategy is the most cross-functional exercise in a company. It sits at the intersection of product (what are we building?), marketing (who are we talking to?), sales (how do we sell it?), and customer success (can we retain them?). When those four functions aren't aligned on the same plan, you get a product that marketing can't position, sales can't sell, and CS can't retain.

This guide covers the five core GTM decisions, the frameworks for making each one, and the sequencing that separates a launch from a crash.

Decision 1: Define Your ICP With Uncomfortable Specificity

Every GTM failure I've been part of started with a vague ICP. "Mid-market SaaS companies" is not an ICP. "B2B SaaS companies with 200-1,000 employees, $20M-$100M ARR, using Salesforce as their CRM, with a VP of Sales or CRO who owns revenue operations" is an ICP. The first targets 50,000+ companies. The second targets 2,000-3,000. The second is sellable.

The ICP validation process

  1. Look at your best customers. If you have them, find the pattern. What industry? What size? What tech stack? What triggered the purchase? Five characteristics that appear in 70%+ of your best accounts form your ICP hypothesis.
  2. Run 20-30 discovery conversations. Not sales calls. Discovery. Talk to potential buyers who match the hypothesis. Ask what they're currently doing, what's painful about it, and what they'd pay to solve it. If 60%+ confirm the pain and express willingness to pay, the hypothesis holds.
  3. Name 500-2,000 specific companies. If you can't build a target account list of at least 500 companies, your ICP might be too narrow. If you can't get it under 5,000, it's too broad. The sweet spot is a list you can realistically cover with your team size.

Common ICP mistakes

  • "Everyone who uses [tool]" is not an ICP. That's a market. An ICP is the subset of that market that will buy your product within 90 days with a deal size that makes your unit economics work.
  • ICP by company size only misses the buyer persona. A 500-person company with an empowered VP of Sales is a different buyer than a 500-person company where the CEO makes every purchasing decision. Both match the firmographic ICP. Only one is sellable in your current motion.
  • Expanding ICP too early. When the first ICP isn't working, the instinct is to go broader. Usually the right move is to go narrower. Find the 200 companies that are the absolute best fit, and close 30 of them before expanding.

Decision 2: Position Around the Problem, Not the Product

Positioning is the story you tell the market about why you exist. Bad positioning describes features. Good positioning describes the problem and the cost of not solving it.

The positioning formula

For [ICP description] who [specific pain point], [product name] is a [category] that [key differentiator]. Unlike [alternative/competitor], we [unique value].

Example: "For mid-market SaaS companies losing 15-20% of revenue to inaccurate forecasting, [Product] is a revenue intelligence platform that predicts quarterly outcomes within 5% accuracy. Unlike spreadsheet-based forecasting, we analyze deal signals across email, calendar, and CRM to surface risk before it becomes a miss."

That positioning tells the buyer: who it's for, what pain it solves, what category it sits in, and why it's different. A rep can deliver that in 30 seconds. A prospect can decide in 10 seconds whether it's relevant to them.

Decision 3: Price for the Buyer, Not the Product

Pricing is a GTM decision, not a finance decision. The right price is what the market will pay, validated through real sales conversations, not what your cost model says you need.

Three pricing approaches for new products

Approach Best For Risk Validation Method
Value-based Products with quantifiable ROI Requires proof of value 10-15 customer interviews on willingness to pay
Competitive Established categories with known pricing Race to the bottom Competitor pricing analysis + differentiation premium
Cost-plus Commoditized services Ignores market willingness Margin target + market rate check

For B2B SaaS, value-based pricing is almost always right. Start with the pain: "Inaccurate forecasting costs a $50M ARR company $5M-$8M in missed pipeline per year." Price at 10-20% of the value you create: $500K-$1.6M range, anchored at $750K. Then test that price in 10-15 sales conversations. If more than 50% of qualified buyers push back on price, it's too high. If nobody pushes back, it's too low.

Pricing for market entry

When entering a new market with established competitors, price 20-30% below the incumbent. Not because you're worth less, but because you're unproven. Buyers need a financial incentive to take the risk of switching. Once you have 20-30 customers and can demonstrate results, increase prices for new customers by 10-15% annually. Existing customers stay at their contracted rate until renewal.

Decision 4: Choose Channels Based on ACV and Complexity

Your sales channel should match your deal size and buying complexity. Mismatched channels burn cash.

ACV Range Primary Channel Sales Motion Typical Team
$0-$5K Self-serve / PLG No human touch until upgrade Product + growth marketing
$5K-$25K Inside sales / SDR-led Demo, 1-2 calls, e-sign SDR + SMB AE
$25K-$100K Field sales / mid-market Multi-meeting, multi-stakeholder SDR + MM AE + SE
$100K-$500K Enterprise sales Consultative, 3-9 month cycle Enterprise AE + SE + exec sponsor
$500K+ Strategic / named account Land and expand, multi-year Strategic AE + SE + CSM + exec team

Selling a $10K product with an enterprise sales team means you need 100+ deals per rep per year to justify their OTE. That's 2 deals per week, which is impossible in a consultative motion. Selling a $200K product through self-serve means you're leaving massive revenue on the table because nobody is helping the buyer navigate a complex purchase. Match the channel to the ACV.

Decision 5: Sequence the Launch, Don't Spray

Launches fail when companies try to do everything simultaneously: build pipeline, close deals, run events, produce content, launch partner programs, and hire a team. The bandwidth doesn't exist. Sequence in phases.

Phase 1: Validate (Weeks 1-8)

Founders or senior leaders close the first 5-10 deals. No SDRs, no marketing automation, no partner channel. Just direct outreach to ICP prospects, discovery conversations, and hands-on selling. The goal isn't revenue. It's learning. What objections come up? What's the real buying process? How long does the cycle take? What price does the market accept?

Phase 2: Systematize (Weeks 8-16)

Document the sales process that worked in Phase 1. Build a repeatable pitch deck, demo script, objection handling guide, and proposal template. Hire 2-3 reps and have them follow the playbook. If they can close at 50-60% of the founder's rate, the process is transferable. If they can't, the playbook needs more work before you scale.

Phase 3: Scale (Weeks 16-26)

Now hire ahead. Add SDRs. Launch marketing campaigns. Activate partner channels. Build the machine. This phase only works if Phases 1 and 2 validated the motion. Scaling an unvalidated GTM is how companies burn $2M-$5M in a quarter with nothing to show for it.

Phase 4: Optimize (Weeks 26+)

Measure everything. Identify bottlenecks. Is the pipeline problem at the top (not enough meetings), the middle (low conversion), or the bottom (slow closing)? Each bottleneck has a different fix. Top-of-funnel: more SDRs or better targeting. Middle: better demos or positioning. Bottom: pricing, procurement support, or champion development.

GTM Metrics That Actually Matter

Track leading indicators in the first 90 days, not revenue. Revenue is a lagging indicator that tells you what happened 3-6 months ago, not what's happening now.

  • Meetings booked per week: Is there demand? Benchmark: 8-12 per SDR per week for outbound, 15-20 for inbound qualification.
  • Demo-to-opportunity rate: Does the message resonate? Benchmark: 40-60% for well-targeted prospects.
  • Average sales cycle: How long does the buyer take? If it's longer than expected, the value proposition isn't compelling enough or you're selling to the wrong buyer persona.
  • Win rate by competitor: Are you winning against specific alternatives? Below 25% win rate against a particular competitor means your positioning or product needs work in that context.
  • Customer activation rate: Do customers actually use the product after buying? Below 70% activation within 30 days signals a gap between what you sold and what you delivered.

New Market Entry: Adjacent vs. New

Entering a new market is different from launching a new product in your existing market. The GTM complexity increases significantly because you're building credibility, references, and market knowledge simultaneously.

Adjacent market entry (same product, new vertical)

Your product works for healthcare. You want to sell it to financial services. The product is largely the same, but the buyer personas, compliance requirements, sales cycles, and competitive landscape are different. Start with 5-10 design partner deals at reduced pricing. These customers provide vertical-specific references, case studies, and product feedback. Don't hire vertical-specific reps until you have 10+ customers and a documented sales process for the new vertical.

New market entry (new geography)

Expanding from the US to EMEA or APAC adds language, timezone, legal, and cultural complexity. The typical approach: hire a country manager 6 months before revenue targets, give them 2-3 reps, and set expectations around market development, not quota attainment, for the first two quarters. A new geography is essentially a startup within the company. Treat it that way.

Common GTM Mistakes

Mistake 1: Hiring sales before proving the motion

The #1 GTM mistake. Founders close 3 deals through personal network, declare PMF, hire 10 reps. The reps can't replicate the founder's relationships. Eight of them miss quota. Six leave within a year. $1.5M in comp and recruiting burned for 3 quarters of learning you could have gotten with 2 reps and a documented playbook.

Mistake 2: Launching without competitive positioning

Your prospect is evaluating 3 vendors. If you can't articulate why you're different from the other two in a single sentence, you're competing on price by default. Competitive positioning should be part of the GTM plan before the first outbound email is sent.

Mistake 3: Broad ICP to maximize TAM

VCs love big TAM numbers. Customers don't care about your TAM. They care about whether your product solves their specific problem. A narrow ICP with 70% win rates generates more revenue than a broad ICP with 15% win rates. Start narrow. Expand after dominating the beachhead.

Mistake 4: Channel partnerships before direct sales mastery

If you can't sell the product yourself, a partner can't sell it either. Partners amplify an existing motion. They don't create one. Master direct sales first. Then identify partners whose customer base overlaps with your ICP and whose product is complementary to yours.